Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart

Endothelium: Journal of Endothelial Cell Research

Volumn 5, Issue 4, 1997, Pages 265-275

  Anning, Peter B ^a,b   Grocott Mason, Richard M ^a   Lewis, Malcolm J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

ACE inhibitors; Bradykinin; LV relaxation; Nitric oxide; Sulphydryl group

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; ICATIBANT; LISINOPRIL; QUINAPRILAT; SUPEROXIDE DISMUTASE; ZOFENOPRILAT;

ANIMAL TISSUE; ARTICLE; FEMALE; GUINEA PIG; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE RELAXATION; HEART RATE; HEART WORK; ISOLATED HEART; MALE; NONHUMAN;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0031461945     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.3109/10623329709052591     Document Type: Article

References (34)

1. Anning, P. B., Grocott-Mason, R. M., Lewis, M. J., Shah, A. M. (1995) Enhancement of left ventricular relaxation in the isolated heart by an angiotensin converting-enzyme inhibitor. Circulation 92, 2660-2665.
2. Bao, G., Qadri, F., Stauss, H., Gohlke, P., Unger, T. (1991) HOE 140, a highly potent and long-acting bradykinin antagonist in conscious rats. Eur. J. Pharmacol. 200, 179-182.
3. Baumgarten, C. R., Linz, W., Kunkel, G., Schölkens, B. A., Wiemer, G. (1993) Ramiprilat increases bradykinin outflow from isolated hearts of rat. British J. Pharmacol. 108, 293-295.
4. Brutsaert, D. L., Meulemans, A. L., Sipido, K. R., Sys, S. U. (1988) Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ. Res. 62, 358-366.
5. Brutsaert, D. L., Sys, S. U. (1989) Relaxation and diastole of the heart. Physiol. Rev. 69, 1228-1315.
6. Busse, R. & Lamontagne, D. (1991) Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme in human endothelial cells. Naunyn-Schmiedberg's Arch. Pharmacol. 344, 126-129.
7. The CONSENSUS Trial Study Group. (1987) Effect of enalapril on mortality in severe congestive heart failure. Results of of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Eng. J. Med. 316, 1429-1435.
8. Friedrich, S. P., Lorell, B. H., Rousseau, M. F., Hayashida, W., Hess, O. M., Douglas, P. S., Gordon, S., Keighley, C., Benedict, C., Krayenbuehl, H. P., Grossman, W., Pouleur, H. (1994) Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 90, 2761-2771.
9. de Graeff, P. A., & van Gilst, W. H. (1992) The effect of bradykinin on coronary flow and its potentiation by SH-containing ACE inhibitors. Agents Actions 38, 110-118.
10. Gohlke, P., Linz, W., Schölkens, B. A., Kuwer, I., Bartenbach, S., Schnell, A., Unger, T. (1994) Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 23, 411-418.
11. Goldschmidt, J. E., Tallarida, R. J. (1991) Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: Effect of sulfhydryl groups on endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther. 257, 1136-1145.
12. Grocott-Mason, R. M., Fort, S., Lewis, M. J., Shah, A. M. (1994a) Myocardial relaxant effect of exogenous nitric oxide in isolated ejecting hearts. Am. J. Physiol. 266, H1699-H1705.
13. Grocott-Mason, R. M., Anning, P. B., Evans, H. G., Lewis, M. J., Shah, A. M. (1994b) Modulation of left ventricular relaxation in the isolated ejecting heart by an endogenous nitric oxide-mediated pathway. Am. J. Physiol. 267, H1804-H1813.
14. Hecker, M., Pörsti, I., Bara, A. T., Busse, R. (1994) Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level. Br. J. Pharmacol. 111, 238-244.
15. Illiano, S., Mombouli, J. V., Nagao, T., Vanhoutte, P. M. (1994) Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin. J. Cardiovasc. Pharmacol. 23, S6-S10.
16. Mancini, G. B., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H., Lüscher, T. F., Klibaner, M. I., Haber, H. E., Uprichard, A. C. G., Pepine, C. J., Pitt, B. (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 94, 258-265.
17. Mombouli, J. V., Illiano, S., Nagao, T., Scott-Burden, T., Vanhoutte, P. M. (1992) Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ. Res. 71, 137-144.
18. Paulus, W. J., Vantrimpont, P. J., Shah, A. M. (1994) Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation 89, 2070-2078.
19. Paulus, W. J., Vantrimpont, P. J. and Shah, A. M. (1995) Paracrine coronary endothelial control of left ventricular function in humans. Circulation 92, 2119-2126.
20. Pelc, L. R., Gross, G. J., Warltier, D. C. (1991) Mechanism of coronary vasodilation produced by bradykinin. Circulation 83, 2048-2056.
21. Pfitzer, G., Rüegg, J., Flockerzi, V., Hofmann, F. (1982) cGMP-dependent protein kinase decreases calcium sensitivity of skinned cardiac fibers. FEBS Lett. 149, 171-175.
22. Rajagopolan, S. & Harrison, D. G. (1996) Reversing endothelial dysfunction with ACE inhibitors. A new TREND?. Circulation 94, 240-43 disparity
23. Schrör, K. (1992) Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J. Cardiovasc. Pharmacol. 20, S68-S73.
24. Shah, A. M., Lewis, M. J., Henderson, A. H. (1991) Effects of 8-bromo-cyclic GMP on contraction and on inotropic response of ferret cardiac muscle. J. Mol. Cell Cardiol. 23, 55-64.
25. 2+ in intact cardiac myocytes. Circ. Res. 74, 970-978.
26. Smith, J. A., Shah, A. M., Lewis, M. J. (1991) Factors released from endocardium of the ferret and pig modulate myocardial contraction. J. Physiol. 439, 1-14.
27. Stamler, J. S., Simon, D. I., Osborne, J. A., Mullins, M. E., Jaraki, O., Michel, T., Singel, D. J., Loscalzo, J. (1992) S-Nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. 89, 444-448.
28. The SOLVD Investigators. (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 327, 685-691.
29. Unger, T., Ganten, D., Lang, R. E. (1986) Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors. J. Cardiovasc. Pharmacol. 8, S75-S81.
30. Unger, T., Gohlke, P. (1994) Converting enzyme inhibitors in cardiovascular therapy: current status and future potential. Cardiovas. Res. 28, 146-158.
31. van Gilst, W. H., de Graeff, P. A., de Leeuw, M. J., Scholtens, E., Wesseling, H. (1991) Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators. J. Cardiovasc. Pharmacol. 18, 429-436.
32. Vanhoutte, P. M., Auch-Schwelk, W., Biondi, M. L., Lorenz, R. R., Schini, V. B., Vidal, M. J. (1989) Why are converting enzyme inhibitors vasodilators? Br. J. Clin. Pharmacol. 28, 95S-104S.
33. Weiss, J. L., Frederiksen, J. W., Weisfedt, M. L. (1976) Hemodynamic determination of the time-course of fall in canine left ventricular pressure. J. Clin. Invest. 58, 751-60.
34. Wirth, K., Hock, F., Albus, U., Linz, W., Alperman, H., Anagnostopoulos, H., Henke, S., Breipohl, G., Konig, W., Knolle, J. and Schölkens, B. (1991) HOE 140, a new potent and long-acting bradykinin antagonist: in vivo studies. Br. J. Pharmacol. 102, 774-777.